South & Central America Neurostimulation Devices Market Forecast to 2030

South & Central America Neurostimulation Devices Market Forecast to 2030

South & Central America Neurostimulation Devices Market Forecast to 2030 – Regional Analysis – by Product (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, and Others), Application (Pain Management, Epilepsy, Urinary and Fecal Incontinence, Parkinson’s Disease, and Others), and End User (Hospitals, Specialty Clinics, and Others)

Send Enquiry
Item ID: BMIRE00030038 Category: Tag:

$2,485 – $3,885

Description

The South & Central America neurostimulation devices market was valued at US$ 303.15 million in 2022 and is expected to reach US$ 575.30 million by 2030; it is estimated to register a CAGR of 8.3% from 2022 to 2030.

Growing Advances and Approvals for Neurostimulation Devices Drive South & Central America Neurostimulation Devices Market

Manufacturers are investing a significant amount in developing advanced products and technologies such as implantable neurostimulation devices. Additionally, an increase in Food and Drug Administration (FDA) approvals for novel neurostimulators with new applications are observed in the neurostimulation devices market. Following are a few advances and approvals for the neurostimulation devices, in March 2021, Abbott launched NeuroSphere, a virtual clinic designed to help deep brain stimulation patients program and reset their devices remotely from the comfort of their own homes. In January 2021, Boston Scientific Corporation released the WaveWriter Alpha, a portfolio of Spinal Cord Stimulator (SCS) systems that combine therapy options for personalized pain relief.

Therefore, the rising number of advances and approvals for neurostimulation devices is expected to provide lucrative opportunities for the neurostimulation devices market during the forecast period.

South & Central America Neurostimulation Devices Market Overview

The South & Central America neurostimulation devices market is segmented into Brazil, Argentina, and the Rest of South & Central America. South & Central America occupies a significant position in the market, and the market in the region is estimated to grow during the forecast period. The neurostimulation devices market is driven by factors such as the rising incidence of neurologic disorders and stroke, growing geriatric population, increasing development in the healthcare systems, rising awareness about neurological disorders, and growing product innovations by market players. In Brazil, the aging population is rapidly growing. According to the data from the Pan American Health Organization (PAHO), Brazil has over 30 million people aged 60 years and older, representing 13% of the country’s population. By 2030, this age group is expected to reach ~50 million, representing 24% of the Brazilian population. As per the Brazil Statistical Institute, the country’s population aged 65 and above is expected to hold a 36% share of the total population of Brazil by 2050. Further, the prevalence of neurological disorders is dependent on the geriatric population in Brazil; thus, the increasing incidence of neurological diseases, such as Parkinson’s disease and Alzheimer’s disease, is likely to propel the demand for neurostimulation devices for treatment.

South & Central America Neurostimulation Devices Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Neurostimulation Devices Market Segmentation

The South & Central America neurostimulation devices market is segmented based on product, application, end user, and country.

Based on product, the South & Central America neurostimulation devices market is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held the largest market share in 2022.

In terms of application, the South & Central America neurostimulation devices market is segmented into pain management, epilepsy, urinary and fecal incontinence, Parkinson’s disease, and others. The pain management segment held the largest market share in 2022.

By end user, the South & Central America neurostimulation devices market is categorized into hospitals, specialty clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the South & Central America neurostimulation devices market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America neurostimulation devices market share in 2022.

Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, and LivaNova Plc are among the leading companies operating in the South & Central America neurostimulation devices market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

,

Year of Publication:

At 8.3% CAGR, South & Central America Neurostimulation Devices Systems Market is Speculated to be Worth US$ 575.30 Million by 2030, says the Research Team

According to the Research Team’ research, the South & Central America neurostimulation devices market was valued at US$ 303.15 million in 2022 and is expected to reach US$ 575.30 million by 2030, registering a CAGR of 8.3% from 2022 to 2030. Rising demand for noninvasive treatment and growing advances and approvals for neurostimulation devices are among the critical factors attributed to the South & Central America neurostimulation devices market expansion.

Neurostimulation is a rapidly evolving field that uses targeted electrical, mechanical, magnetic, or thermal stimulation of the nervous system to alter the properties of firing neuronal and internal neuronal connectivity to treat various neurological disorders. Noninvasive neurostimulation devices include electroconvulsive therapy (ECT), transcutaneous electrical nerve stimulation (TENS), transcranial electrical stimulation (TES), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), static magnetic stimulation, random sound stimulation, peripheral nerve stimulation, ultrasound, and focused ultrasound (FUS), including cranial nerve stimulation. Noninvasive neurostimulation techniques are the most developed in psychiatry. Patients and healthcare providers increasingly prefer noninvasive or minimally invasive treatment options as they are convenient, painless, safe, and have minimal side effects. In addition, it is widely used in neurological diseases. Noninvasive treatments aim to improve the quality of life and reduce the impact of speech, swallowing, and cognitive problems. Therefore, growing demand for noninvasive treatments would significantly fuel the neurostimulation devices market growth in the future.

On the contrary, lack of expert professionals hampers the growth of South & Central America neurostimulation devices market.

Based on product, the South & Central America neurostimulation devices market is categorized into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held 50.3% market share in 2022, amassing US$ 152.34 million. It is projected to garner US$ 301.35 million by 2030 to expand at 8.9% CAGR during 2022-2030.

In terms of application, the South & Central America neurostimulation devices market is segmented into pain management, epilepsy, urinary and fecal incontinence, Parkinson’s disease, and others. The pain management segment held 51.7% share of South & Central America neurostimulation devices market in 2022, amassing US$ 156.68 million. It is projected to garner US$ 311.88 million by 2030 to expand at 9.0% CAGR during 2022-2030.

By end user, the South & Central America neurostimulation devices market is categorized into hospitals, specialty clinics, and others. The hospitals segment held 58.4% share of South & Central America neurostimulation devices market in 2022, amassing US$ 177.12 million. It is projected to garner US$ 341.37 million by 2030 to expand at 8.5% CAGR during 2022-2030.

Based on country, the South & Central America neurostimulation devices market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 58.7% share of South & Central America neurostimulation devices market in 2022. It was assessed at US$ 177.87 million in 2022 and is likely to hit US$ 347.59 million by 2030, exhibiting a CAGR of 8.7% during 2022-2030.

Key players operating in the South & Central America neurostimulation devices market are Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, and LivaNova Plc, among others.

In August 2023, FDA approved Abbott’s new spinal cord stimulation device provides tailored relief to multiple pain areas and adds more treatment options for evolving pain condition.

In February 2020, LivaNova Collaborated with Verily to Gain New Insights into Vagus Nerve Stimulation Impact on Difficult-to-Treat Depression.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America neurostimulation devices market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America neurostimulation devices market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America neurostimulation devices market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Neurostimulation Devices Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Neurological Disorders
4.1.2 Rising Cases of Spinal Cord Injury
4.2 Market Restraints
4.2.1 Lack of Expert Professionals
4.3 Market Opportunities
4.3.1 Growing Advances and Approvals for Neurostimulation Devices
4.4 Future Trends
4.4.1 Rising Demand for Noninvasive Treatment
4.5 Impact Analysis
5. Neurostimulation Devices Market – South & Central America Market Analysis
5.1 South & Central America Neurostimulation Devices Market Revenue (US$ Mn), 2022 – 2030
6. South & Central America Neurostimulation Devices Market – Revenue and Forecast to 2030 – by Product
6.1 Overview
6.2 South & Central America Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Spinal Cord Stimulator
6.3.1 Overview
6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Deep Brain Stimulator
6.4.1 Overview
6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Sacral Nerve Stimulator
6.5.1 Overview
6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Vagus Nerve Stimulator
6.6.1 Overview
6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Neurostimulation Devices Market – Revenue and Forecast to 2030 – by Application
7.1 Overview
7.2 South & Central America Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Pain Management
7.3.1 Overview
7.3.2 Pain Management: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Epilepsy
7.4.1 Overview
7.4.2 Epilepsy: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Urinary and Fecal Incontinence
7.5.1 Overview
7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Parkinson’s Disease
7.6.1 Overview
7.6.2 Parkinson’s Disease: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Neurostimulation Devices Market – Revenue and Forecast to 2030 – by End User
8.1 Overview
8.2 South & Central America Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Specialty Clinics
8.4.1 Overview
8.4.2 Specialty Clinics: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Neurostimulation Devices Market – Revenue and Forecast to 2030 – Country Analysis
9.1 South & Central America: Neurostimulation Devices Market
9.1.1 Overview
9.1.2 South & Central America: Neurostimulation Devices Market Share by Country – 2022 & 2030, (%)
9.1.2.1 Brazil: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
9.1.2.2 Brazil: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.2.1 Brazil: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
9.1.2.2.2 Brazil: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
9.1.2.2.3 Brazil: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)
9.1.2.3 Argentina: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
9.1.2.4 Argentina: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.4.1 Argentina: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
9.1.2.4.2 Argentina: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
9.1.2.4.3 Argentina: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)
9.1.2.5 Rest of South & Central America: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
9.1.2.6 Rest of South & Central America: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.6.1 Rest of South & Central America: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
9.1.2.6.2 Rest of South & Central America: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
9.1.2.6.3 Rest of South & Central America: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)
10. Neurostimulation Devices Market-Industry Landscape
10.1 Overview
10.2 Organic Developments
10.2.1 Overview
10.3 Inorganic Developments
10.3.1 Overview
11. Company Profiles
11.1 Medtronic Plc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Boston Scientific Corp
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Abbott Laboratories
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 LivaNova Plc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms

LIST OF TABLES

Table 1. Neurostimulation Devices Market Segmentation
Table 2. Brazil Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil: Neurostimulation Devices Market, By Application – Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil: Neurostimulation Devices Market, By End User – Revenue and Forecast to 2030 (US$ Million)
Table 5. Argentina Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 6. Argentina: Neurostimulation Devices Market, By Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. Argentina: Neurostimulation Devices Market, By End User – Revenue and Forecast to 2030 (US$ Million)
Table 8. Rest of South & Central Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 9. Rest of South & Central America: Neurostimulation Devices Market, By Application – Revenue and Forecast to 2030 (US$ Million)
Table 10. Rest of South & Central America: Neurostimulation Devices Market, By End User – Revenue and Forecast to 2030 (US$ Million)
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms, Neurostimulation Devices Market

LIST OF FIGURES

Figure 1. Neurostimulation Devices Market Segmentation, By Country
Figure 2. Neurostimulation Devices Market: Key Industry Dynamics
Figure 3. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Neurostimulation Devices Market Revenue (US$ Mn), 2020 – 2030
Figure 5. South & Central America Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Spinal Cord Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Deep Brain Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Sacral Nerve Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Vagus Nerve Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. South & Central America Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Pain Management: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Epilepsy: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Urinary and Fecal Incontinence: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Parkinson’s Disease: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. South & Central America Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
Figure 18. Hospitals & Clinics: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Specialty Clinics: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. South & Central America: Neurostimulation Devices Market, By Key Country – Revenue (2022) (US$ Million)
Figure 22. South & Central America: Neurostimulation Devices Market Share by Country – 2022 & 2030, (%)
Figure 23. Brazil: Neurostimulation Devices Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 24. Argentina: Neurostimulation Devices Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 25. Rest of South & Central America: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)

The List of Companies – South & Central America Neurostimulation Devices Market

1. Medtronic Plc
2. Boston Scientific Corp
3. Abbott Laboratories
4. LivaNova Plc

Reviews

There are no reviews yet.

Be the first to review “South & Central America Neurostimulation Devices Market Forecast to 2030”